Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

BVR was not better than BR for MCL induction in the phase II ECOG-ACRIN E1411 trial. Median PFS was 64.1 v 64

  • BVR was not better than BR for MCL induction in the phase II ECOG-ACRIN E1411 trial. Median PFS was 64.1 v 64 months.